The podcast features experts in CLL therapy discussing topics like the impact of MRD, comparative analysis of BTK inhibitors, challenges in defining cure, selecting BTKIs in frontline therapy, and optimizing treatment strategies for young CLL patients. They debate on therapy duration, patient outcomes, and future approaches in treating high-risk CLL patients.